{"disease":{"id":"infectious-mononucleosis","name":"infectious mononucleosis"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06908096","title":"Epstein-Barr Virus (EBV) gH/gL/gp42-Ferritin Nanoparticle Vaccine With or Without gp350-Ferritin in Healthy Adults With or Without EBV Infection","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":750,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT05778006","title":"Multi-Center Registry for ME/CFS","phase":"","overall_status":"RECRUITING","enrollment_count":650,"lead_sponsor_name":"Technical University of Munich","has_results":false},{"nct_id":"NCT06002802","title":"Study on Infectious Mononucleosis in Munich","phase":"","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"Technical University of Munich","has_results":false},{"nct_id":"NCT04645147","title":"Safety and Immunogenicity of an Epstein-Barr Virus (EBV) gp350-Ferritin Nanoparticle Vaccine in Healthy Adults With or Without EBV Infection","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":83,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT05683834","title":"Trial Evaluating the Immunogenicity and Safety of an Adjuvanted Epstein-Barr Virus (EBV) Glycoprotein 350 Vaccine in EBV-seronegative Persons","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":25,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT05664711","title":"Effect of Stellate Ganglion Block on ME/CFS","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"Neuroversion, Inc.","has_results":false}],"total":6},"guidelines":[],"source":"Drug Landscape verified database"}